Health Interventions for Firefighter Cardiovascular Risk Reduction
(FCRP Trial)
Trial Summary
What is the purpose of this trial?
The goal of this research is to test interventions to reduce firefighter cardiovascular, cognitive, and overall disease risks, including but not limited to risks associated with Per- and Polyfluorinated Substances (PFAS) exposure. Approximately 1,500 - 2,000 firefighters will be enrolled in the Fire Fighter Cancer Cohort Study (FFCCS). Among these individuals, those that express interest will then be screened for eligibility for the Firefighter Collaborative Research Project (FCRP) using information they provided for the Fire Fighter Cancer Cohort Study. Firefighters enrolled in the study will provide an initial blood sample and urine sample. The blood sample will be analyzed to determine the participant's PFAS levels. Based upon serum PFAS levels and responses from the screening survey, eligible participants will be randomly assigned into one of the following interventions: 1. Blood Donation, or Plasma Donation or Blood/Plasma Control Group; 2. Zone 2 Training or Zone 2 Control; 3. Intermittent Fasting or Intermittent Fasting Control. Individuals participating in the blood donation, plasma donation or blood/plasma control group would donate blood every 12 weeks, plasma every 6 weeks, or not donate blood or plasma. Participants in this intervention arm would continue this for a 12-month period. Individuals in the zone 2 training, zone 2 training control, intermittent fasting or intermittent fasting control group would participate in their intervention or control for a 4-month period. After 4 to 12 months participating in an intervention or control group, participants will be asked to provide a final urine sample and blood draw to determine if and to what degree their PFAS levels or other cardiovascular disease and other health risks have changed.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are using antidiabetic medications like Semaglutide or Tirzepatide, you may be excluded from the intermittent fasting group.
What data supports the effectiveness of the treatment for reducing cardiovascular risk in firefighters?
Research shows that time-restricted feeding can reduce inflammation and stress responses in firefighters, which may help lower their risk of heart disease. Additionally, alternate-day fasting combined with exercise has been found to improve body weight and blood fat levels, which are important for heart health.12345
Is alternate-day fasting safe for humans?
How does the treatment for reducing cardiovascular risk in firefighters differ from other treatments?
This treatment is unique because it focuses on dietary interventions, such as time-restricted feeding and the Mediterranean diet, to reduce cardiovascular risk in firefighters. These approaches aim to improve health by changing eating patterns and food choices, rather than relying on medication.15111213
Eligibility Criteria
This trial is for active Arizona firefighters over 18, who plan to stay in service for the next 2 years and are part of the Fire Fighter Cancer Cohort Study. They must speak English fluently, have a BMI over 17.5 kg/m2, weigh more than 115 pounds, and be able to donate blood if needed. Smokers or those with significant health issues can't participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Participants provide an initial blood sample and urine sample to determine PFAS levels
Intervention
Participants are randomly assigned to interventions: Blood/Plasma Donation, Zone 2 Training, or Intermittent Fasting, or their respective control groups
Final Assessment
Participants provide a final urine sample and blood draw to assess changes in PFAS levels and other health risks
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Blood Donation
- Intermittent Fasting
- Plasma Donation
- Zone 2 Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
Arizona State University
Collaborator